{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:29:58Z","timestamp":1792553398769,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693643"],"award-info":[{"award-number":["2021M693643"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372986"],"award-info":[{"award-number":["82372986"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515111073"],"award-info":[{"award-number":["2021A1515111073"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["23xkjc018"],"award-info":[{"award-number":["23xkjc018"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017380","name":"Science and Technology Foundation of Shenzhen City","doi-asserted-by":"publisher","award":["JCYJ20210324114402006"],"award-info":[{"award-number":["JCYJ20210324114402006"]}],"id":[{"id":"10.13039\/100017380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20180301170035531"],"award-info":[{"award-number":["JCYJ20180301170035531"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.canlet.2024.216836","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T01:56:25Z","timestamp":1711763785000},"page":"216836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer"],"prefix":"10.1016","volume":"589","author":[{"given":"Yi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7931-7427","authenticated-orcid":false,"given":"Fengtian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4953-3134","authenticated-orcid":false,"given":"Wenting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2024.216836_bib1","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1002\/jcp.29494","article-title":"PD-1\/PD-L1-dependent immune response in colorectal cancer","volume":"235","author":"Payandeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2024.216836_bib2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.216836_bib3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2024.216836_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2024.216836_bib5","article-title":"Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside","volume":"1874","author":"Lizardo","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2024.216836_bib6","first-page":"1","article-title":"Immunotherapy for microsatellite stable colorectal cancers: challenges and novel therapeutic avenues","volume":"42","author":"Sahin","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.canlet.2024.216836_bib7","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2024.216836_bib8","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.21.02691","article-title":"Mismatch repair-deficient colorectal cancer: building on checkpoint blockade","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216836_bib9","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41416-019-0599-y","article-title":"Immune checkpoint inhibitors for the treatment of MSI-H\/MMR-D colorectal cancer and a perspective on resistance mechanisms","volume":"121","author":"Sahin","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2024.216836_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2024.216836_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2024.216836_bib12","first-page":"30","article-title":"The role of deubiquitinating enzymes in gastric cancer","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2024.216836_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0092-8674(02)01199-6","article-title":"Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde","volume":"111","author":"Hu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216836_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12943-020-01262-x","article-title":"The role of ubiquitination and deubiquitination in cancer metabolism","volume":"19","author":"Sun","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.216836_bib15","article-title":"Deubiquitinases in cancers: aspects of proliferation, metastasis, and apoptosis","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.216836_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090848","article-title":"Ubiquitin-specific proteases: players in cancer cellular processes","volume":"14","author":"Cruz","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.canlet.2024.216836_bib17","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1158\/0008-5472.CAN-14-1211","article-title":"Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer","volume":"74","author":"Pal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216836_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2024.216836_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2010.07.002","article-title":"K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling","volume":"33","author":"Huang","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216836_bib20","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41467-022-29401-6","article-title":"USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy","volume":"13","author":"Xiong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216836_bib21","doi-asserted-by":"crossref","first-page":"11002","DOI":"10.1074\/jbc.M111.328187","article-title":"Ubiquitin-specific protease 4 mitigates Toll-like\/interleukin-1 receptor signaling and regulates innate immune activation","volume":"287","author":"Zhou","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216836_bib22","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1111\/j.1582-4934.2008.00682.x","article-title":"The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway","volume":"13","author":"Zhao","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2024.216836_bib23","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.molonc.2015.06.006","article-title":"Ubiquitin specific protease 4 positively regulates the WNT\/beta-catenin signaling in colorectal cancer","volume":"9","author":"Yun","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.canlet.2024.216836_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1158\/0008-5472.CAN-14-3595","article-title":"Ubiquitin-specific protease 4-mediated deubiquitination and stabilization of PRL-3 is required for potentiating colorectal oncogenesis","volume":"76","author":"Xing","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.216836_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1042\/BJ20111358","article-title":"Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFalpha-induced cancer cell migration","volume":"441","author":"Xiao","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2024.216836_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41419-017-0182-5","article-title":"Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2024.216836_bib27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/1873-3468.12668","article-title":"USP4 interacts and positively regulates IRF8 function via K48-linked deubiquitination in regulatory T cells","volume":"591","author":"Lin","year":"2017","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2024.216836_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2159-8290.CD-23-0584","article-title":"Receptor-interacting protein kinase 2 is an immunotherapy target in pancreatic cancer","volume":"14","author":"Sang","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216836_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061582","article-title":"The deubiquitinase USP4 stabilizes Twist1 protein to promote lung cancer cell stemness","volume":"12","author":"Li","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.216836_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 Axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.216836_bib31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.20122844","article-title":"USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase","volume":"211","author":"Fan","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2024.216836_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216836_bib33","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nri3133","article-title":"Immunomodulatory functions of type I interferons","volume":"12","author":"Gonzalez-Navajas","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccell.2020.11.015","article-title":"Conserved interferon-gamma signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"39","author":"Grasso","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2024.216836_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-017-0691-y","article-title":"Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies","volume":"16","author":"Berg","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2024.216836_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216836_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041356","article-title":"Double-stranded RNA sensors and modulators in innate immunity","volume":"37","author":"Hur","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.immuni.2020.04.004","article-title":"Nucleic acid sensors as therapeutic targets for human disease","volume":"53","author":"McWhirter","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216836_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216836_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41577-020-0288-3","article-title":"RIG-I-like receptors: their regulation and roles in RNA sensing","volume":"20","author":"Rehwinkel","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib43","doi-asserted-by":"crossref","first-page":"15325","DOI":"10.1074\/jbc.R700002200","article-title":"Triggering the innate antiviral response through IRF-3 activation","volume":"282","author":"Hiscott","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2024.216836_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molcel.2009.09.037","article-title":"Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3","volume":"36","author":"Zeng","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2024.216836_bib45","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jaut.2018.07.019","article-title":"Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders","volume":"94","author":"Lu","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.canlet.2024.216836_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4049\/jimmunol.2000891","article-title":"Zebrafish otud6b negatively regulates antiviral responses by suppressing K63-linked ubiquitination of irf3 and irf7","volume":"207","author":"Zhou","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib47","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1038\/onc.2015.349","article-title":"USP4 inhibits p53 and NF-\u03baB through deubiquitinating and stabilizing HDAC2","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2024.216836_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(19)32998-8","article-title":"Deep learning for prediction of colorectal cancer outcome: a discovery and validation study","volume":"395","author":"Skrede","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2024.216836_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2024.216836_bib50","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.216836_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2024.216836_bib52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2024.216836_bib53","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing Ido1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2024.216836_bib54","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216836_bib55","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13140","article-title":"Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I","volume":"509","author":"Peisley","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2024.216836_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00321-18","article-title":"TRIM21 promotes innate immune response to RNA viral infection through lys27-linked polyubiquitination of MAVS","volume":"92","author":"Xue","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2024.216836_bib57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.immuni.2010.10.013","article-title":"The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA","volume":"33","author":"Tsuchida","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2024.216836_bib58","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cell.2013.01.011","article-title":"Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation","volume":"152","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2024.216836_bib59","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/cdd.2011.11","article-title":"USP4 targets TAK1 to downregulate TNFalpha-induced NF-kappaB activation","volume":"18","author":"Fan","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2024.216836_bib60","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.fsi.2022.11.005","article-title":"Rainbow trout USP4 downregulates LPS-induced inflammation by removing the K63-linked ubiquitin chain on TAK1","volume":"131","author":"Jang","year":"2022","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib61","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1128\/JVI.00031-13","article-title":"USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I","volume":"87","author":"Wang","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2024.216836_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00785","article-title":"MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades","volume":"2","author":"Liu","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.canlet.2024.216836_bib63","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbrc.2019.05.022","article-title":"Ubiquitination of cGAS by TRAF6 regulates anti-DNA viral innate immune responses","volume":"514","author":"Chen","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2024.216836_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.4049\/jimmunol.2100125","article-title":"Zebrafish Uba1 degrades IRF3 through K48-linked ubiquitination to inhibit IFN production","volume":"207","author":"Chen","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2024.216836_bib65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/imm.13315","article-title":"Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF3","volume":"163","author":"Chen","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.canlet.2024.216836_bib66","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1158\/2159-8290.CD-21-0506","article-title":"Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.216836_bib67","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:33:01Z","timestamp":1714177981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":67,"alternative-id":["S0304383524002295"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216836","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.216836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216836"}}